Genmab — Juli 2018
-
Næh for jeg stoler ikke specielt meget på så umodne tal så fint for mig med 480, jeg har de langsigtede briller på og er ret ligeglad med kortsigtede trends. Det virker og det ved både patienter og læger i den internetbaseret verden af i dag, så jeg er helt rolig over udrulningen indtil videre og synes faktisk at den går en smule hurtigere end forventet.
-
God morgen.

-
God morgen

-
Interview – Why Immatics could soon become the next listed cell therapy player - by EPVantage - http://www.epvantage.com/Universal/View.aspx?type=Story&id=802624&isEPVantage=yes
-
-
Mornings - er i klar til usd 530m senere i dag?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind